Investigations of the Effects and Associated Neural Mechanisms of Different Exercise in People With Metabolic Syndrome
2 other identifiers
interventional
120
1 country
1
Brief Summary
Metabolic syndrome (MetS) is a risk for many chronic diseases of middle-aged and older adults. Hence, prevention and treatment of MetS is a crucial global health issue. However, it remains unclear regarding the cognitive effects and associated neural mechanisms of exercise interventions in this population. Therefore, the aims of this three-year project are to compare the effects and neural mechanism of three different types of exercise interventions, on components of MetS, as well as neuropsychological and physical functions in middle-aged and older adults with MetS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 12, 2020
CompletedFirst Submitted
Initial submission to the registry
December 19, 2022
CompletedFirst Posted
Study publicly available on registry
January 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedJanuary 5, 2023
December 1, 2022
3 years
December 19, 2022
January 4, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes of brain functional activation and structure imaging
Functional Magnetic Resonance Imaging (fMRI) activation patterns and white and gray matter changes of the brain
at baseline, 12 weeks exercise intervention
Secondary Outcomes (15)
Neuropsychological test-CANTAB
at baseline, 12 weeks exercise intervention
Neuropsychological test-AD8
at baseline, 12 weeks exercise intervention
Neuropsychological test-MoCA
at baseline, 12 weeks exercise intervention
Neuropsychological test-CDR
at baseline, 12 weeks exercise intervention
Neuropsychological test-CTT
at baseline, 12 weeks exercise intervention
- +10 more secondary outcomes
Study Arms (2)
Aerobic plus resistance training group
EXPERIMENTALReceive three one-hour supervised group sessions weekly for 12 weeks, in which Sections 1 and 3 were AT plus RT sessions, including 5-minute warm-up, 30-minute AT exercises on a bicycle (Comfort 408, Horizon Fitness) or a treadmill (832T, Horizon Fitness), 20-minute RT, and 5-minute cool-down; whereas Section 2 was an AT-only session, including 5-minute warm up, 50-minute aerobic exercises (bicycling or treadmill walking), and 5-minute cool-down.
Stretching plus breathing training group
EXPERIMENTALReceive three one-hour sessions of weekly supervised group training combining Tongtze Gymnastics (童子體操) and breathing exercises for 12 weeks.
Interventions
Aerobic plus resistance training
Stretching plus breathing training
Eligibility Criteria
You may qualify if:
- Age between 45 and 80 years old
- Literacy
- Diagnosed with MetS based on the International Diabetes Federation (IDF) definition (Alberti et al., 2006) The IDF definition of MetS includes central obesity, determined by waist circumference at the midpoint between the lowest rib and iliac crest being ≧ 90 cm for men and ≧ 80 cm for women, plus at least two of the following conditions- (a) TG ≧ 150 mg/dl or being treated for this lipid abnormality, (b) HDL-C \< 40 mg/dl in men, \< 50 mg/dl in women, or being treated for this lipid abnormality, (c) systolic blood pressure (SBP) ≧ 130 mmHg, or systolic blood pressure (DBP) ≧ 85 mmHg, or being treated for diagnosed hypertension, and (d) FPG ≧ 100 mg/dl or diagnosed Type II DM).
- Living with a sedentary lifestyle (defined as being engaged in physical activities for less than a total of 90 minutes per week) (Fletcher et al., 1996) in recent one year.
You may not qualify if:
- Having any contraindications for fMRI (e.g., claustrophobia and indwelling metals or implanted devices)
- Serious or uncontrolled cardiovascular or pulmonary conditions (e.g., unstable angina, serious cardiac arrhythmias, heart failure, hypertrophic cardiomyopathy, severe aortic or carotid stenosis, pulmonary embolus or infarction, resting SBP ≥ 180 mmHg, or resting DBP ≥ 110 mmHg)
- Severe renal failure (Stages 4 and 5 of chronic kidney diseases (Levin et al., 2013)
- Symptoms or histories of neurological diseases, including transient ischemic attack
- Severe musculoskeletal disorders which would affect their mobility
- Diagnosis of dementia, Montreal Cognitive Assessment (MoCA) (Taiwan version) \< 22 (Tsai et al., 2012; Wang et al., 2013), or inability to follow instructions
- Psychiatric disorders (including depression) or Geriatric Depression Scale-short form (GDS-15) score≧8 (Sheikh \& Yesavage, 1986)
- Having contraindications for doing exercises (e.g., resting SBP ≥ 180 mmHg, resting DBP ≥ 110 mmHg, FPG ≥ 300 mg/dL, hypoglycemia (plasma glucose ≤ 70 mg/dL) after exercises, or postural hypotension (BP drop ≥ 20 mmHg when changing postures)
- Life expectancy less than six months due to any disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Collage of Public Health
Taipei, Zhongzheng, 100, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pei-Fang Tang, PhD
National Taiwan University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 19, 2022
First Posted
January 5, 2023
Study Start
August 12, 2020
Primary Completion
July 31, 2023
Study Completion
December 31, 2023
Last Updated
January 5, 2023
Record last verified: 2022-12